ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1934

Improvement in Cryoglobulin Detection Employing a Temperature Controlled Sample Transporter

W. Winn Chatham1, Moon Nahm2 and William H. Benjamin Jr.2, 1University of Alabama at Birmingham, Birmingham, AL, 2Pathology, University of Alabama at Birmingham, Birmingham, AL

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Cryoglobulinemia and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: Optimal conditions for detecting serum cryoglobulins in patients with suspected vasculitis requires drawn blood samples remain at 37 degree F or higher temperature until the sample has clotted and the serum is removed. Failure to maintain these temperature conditions during sample transport to the processing laboratory may lead to failure to detect cryoglobulins and false negative test results. We determined the utility of a custom-designed sample transporter for optimizing the quality of blood samples submitted for cryoglobulin detection.

Methods: A quality study was undertaken in a hospital-based clinical immunology laboratory to assess the frequency of samples sent to the lab for cryoglobulin analysis that were deemed acceptable for optimal cryoglobulin analysis (sample temperature at or greater than 37 degrees C). Following the study, a specially designed blood tube carrier (Cryocab) containing a 300 gram 1:1 mixture of n-docosane and n-eicosane was developed for use in the hospital/clinic pneumatic tube transport systems. The mixture in the carrier melts at 38 degrees C, with a high heat of fusion when solidifying and maintaining a temperature of 38°C for several hours as the material undergoes phase transition. Following implementation of Cryocab use, a subsequent study to determine the frequency of acceptable samples arriving to the clinical immunology lab was undertaken. 

Results: During a ten month time period prior to routine use of the Cryocab, only 146/226 (34%) of samples arriving in the clinical immunology lab for cryoglobulin assessment had a temperature at or exceeding 37 degrees C.  During a four month time frame following implementation of routine Cryocab use by the hospital and clinic phelebotomy services, the percentage of samples arriving to the clinical immunology lab at 37 degrees or higher improved dramatically—87/90 (97%).   

Conclusion: Use of a gel-based transporter to maintain blood samples at temperatures conducive to optimal detection of cryoglobulins can dramatically improve the quality of samples arriving to the analyzing lab, and may improve cryoglobulin detection rates.


Disclosure:

W. W. Chatham,
None;

M. Nahm,
None;

W. H. Benjamin Jr.,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improvement-in-cryoglobulin-detection-employing-a-temperature-controlled-sample-transporter/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology